CON EBITDA

annual EBITDA:

$368.26M+$8.11M(+2.25%)
December 31, 2024

Summary

  • As of today (May 20, 2025), CON annual EBITDA is $368.26 million, with the most recent change of +$8.11 million (+2.25%) on December 31, 2024.
  • During the last 3 years, CON annual EBITDA has fallen by -$21.36 million (-5.48%).
  • CON annual EBITDA is now -5.48% below its all-time high of $389.63 million, reached on December 1, 2021.

Performance

1-year change

+2.25%

3-year change

-5.48%

5-year change

-5.48%

15-year change

-5.48%

CON EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

91.1%
CON annual EBITDA is higher than 91.1% of companies in Healthcare sector

Range

All-time high

$389.63M
CON annual EBITDA is currently -5.48% below its historical high of $389.63 million

3-year low

$330.20M
CON annual EBITDA is currently +11.53% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
CON previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
CON next annual earnings announcement has not yet been scheduled

OtherCONincome statement metrics

Annual revenue

$1.90B
CON annual revenue is $1.90 billion

annual net income

$166.54M
CON annual net profit is $166.54 million

annual EBIT

$301.09M
CON annual earnings before interest & taxes is $301.09 million

Annual EPS

$1.46
CON annual earnings per share is $1.46

quarterly EBITDA:

$96.06M+$21.37M(+28.60%)
March 31, 2025

Summary

  • As of today (May 20, 2025), CON quarterly EBITDA is $96.06 million, with the most recent change of +$21.37 million (+28.60%) on March 31, 2025.
  • Over the past year, CON quarterly EBITDA has increased by +$2.08 million (+2.21%).
  • CON quarterly EBITDA is now -5.31% below its all-time high of $101.45 million, reached on September 30, 2024.

Performance

3-month change

+28.6%

1-year change

+2.21%

3-year change

+3.24%

5-year change

+3.24%

CON quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

90.33%
CON quarterly EBITDA is higher than 90.33% of companies in Healthcare sector

Range

All-time high

$101.45M
CON quarterly EBITDA is currently -5.31% below its historical high of $101.45 million

3-year low

$67.81M
CON quarterly EBITDA is currently +41.66% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CON previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 1, 2025
CON next earnings announcement is scheduled for Aug 1, 2025

OtherCONincome statement metrics

Quarterly revenue

$500.75M
CON quarterly revenue is $500.75 million

quarterly net income

$38.91M
CON quarterly net profit is $38.91 million

quarterly EBIT

$79.44M
CON quarterly earnings before interest & taxes is $79.44 million

Quarterly EPS

$0.30
CON quarterly earnings per share is $0.30

TTM EBITDA:

$370.55M+$2.08M(+0.56%)
March 31, 2025

Summary

  • As of today (May 20, 2025), CON TTM EBITDA is $370.55 million, with the most recent change of +$2.08 million (+0.56%) on March 31, 2025.
  • Over the past year, CON TTM EBITDA has increased by +$9.44 million (+2.61%).
  • CON TTM EBITDA is now at all-time high.

Performance

3-month change

+0.56%

1-year change

+2.61%

3-year change

+298.25%

5-year change

+298.25%

CON TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

90.5%
CON TTM EBITDA is higher than 90.5% of companies in Healthcare sector

Range

All-time high

$370.55M
CON TTM EBITDA is currently at an all-time high

3-year low

$93.04M
CON TTM EBITDA is currently +298.25% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CON previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 1, 2025
CON next earnings announcement is scheduled for Aug 1, 2025

OtherCONincome statement metrics

TTM revenue

$1.93B
CON TTM revenue is $1.93 billion

TTM net income

$156.50M
CON TTM net profit is $156.50 million

TTM EBIT

$305.24M
CON TTM earnings before interest & taxes is $305.24 million

TTM EPS

$1.25
CON TTM earnings per share is $1.25

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$368.26M
CON annual EBITDA is $368.26 million

annual net income

$166.54M
CON annual net profit is $166.54 million

annual interest expense

$69.69M
CON annual interest expense is $69.69 million

annual income tax

$59.50M
CON annual income tax is $59.50 million

annual D&A

$67.18M
CON annual depreciation & amortization is $67.18 million

CON EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.3%+2.2%+2.6%
3 y3 years-5.5%+3.2%+298.3%
5 y5 years-5.5%+3.2%+298.3%

CON EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.5%+11.5%-5.3%+41.7%at high+298.3%
5 y5-year-5.5%+11.5%-5.3%+41.7%at high+298.3%
alltimeall time-5.5%+11.5%-5.3%+41.7%at high+298.3%

CON EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$96.06M(+28.6%)
$370.55M(+0.6%)
Dec 2024
$368.26M(+2.3%)
$74.70M(-26.4%)
$368.47M(+1.9%)
Sep 2024
-
$101.45M(+3.2%)
$361.59M(+0.7%)
Jun 2024
-
$98.34M(+4.6%)
$359.05M(-0.6%)
Mar 2024
-
$93.98M(+38.6%)
$361.11M(+0.3%)
Dec 2023
$360.15M
-
-
DateAnnualQuarterlyTTM
Dec 2023
-
$67.81M(-31.4%)
$360.17M(+23.2%)
Sep 2023
-
$98.91M(-1.5%)
$292.36M(+51.1%)
Jun 2023
-
$100.41M(+7.9%)
$193.45M(+107.9%)
Mar 2023
-
$93.04M
$93.04M
Dec 2022
$330.20M(-15.3%)
-
-
Dec 2021
$389.63M
-
-

FAQ

  • What is Concentra Group Holdings Parent annual EBITDA?
  • What is the all time high annual EBITDA for Concentra Group Holdings Parent?
  • What is Concentra Group Holdings Parent annual EBITDA year-on-year change?
  • What is Concentra Group Holdings Parent quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Concentra Group Holdings Parent?
  • What is Concentra Group Holdings Parent quarterly EBITDA year-on-year change?
  • What is Concentra Group Holdings Parent TTM EBITDA?
  • What is the all time high TTM EBITDA for Concentra Group Holdings Parent?
  • What is Concentra Group Holdings Parent TTM EBITDA year-on-year change?

What is Concentra Group Holdings Parent annual EBITDA?

The current annual EBITDA of CON is $368.26M

What is the all time high annual EBITDA for Concentra Group Holdings Parent?

Concentra Group Holdings Parent all-time high annual EBITDA is $389.63M

What is Concentra Group Holdings Parent annual EBITDA year-on-year change?

Over the past year, CON annual EBITDA has changed by +$8.11M (+2.25%)

What is Concentra Group Holdings Parent quarterly EBITDA?

The current quarterly EBITDA of CON is $96.06M

What is the all time high quarterly EBITDA for Concentra Group Holdings Parent?

Concentra Group Holdings Parent all-time high quarterly EBITDA is $101.45M

What is Concentra Group Holdings Parent quarterly EBITDA year-on-year change?

Over the past year, CON quarterly EBITDA has changed by +$2.08M (+2.21%)

What is Concentra Group Holdings Parent TTM EBITDA?

The current TTM EBITDA of CON is $370.55M

What is the all time high TTM EBITDA for Concentra Group Holdings Parent?

Concentra Group Holdings Parent all-time high TTM EBITDA is $370.55M

What is Concentra Group Holdings Parent TTM EBITDA year-on-year change?

Over the past year, CON TTM EBITDA has changed by +$9.44M (+2.61%)
On this page